Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
Bryn LindleyZubin BhaktaKristine GrayAlexandre WatanabeLaurie LeclairDavid C YoungPublished in: Pediatric pulmonology (2022)
Our results demonstrate that in PwCF intermittent IV vancomycin steady-state PK are similar to previously reported single-dose IV vancomycin. Additionally, CL<sub>vanco</sub> minimally changes from Day 3 to Day 7, although this study was not powered to detect a difference.